Literature DB >> 20938588

Advances in inhalation therapy in pediatrics.

Fábio Pereira Muchão1, Luiz Vicente Ribeiro Ferreira da Silva Filho.   

Abstract

OBJECTIVES: To review the most relevant articles regarding the technical aspects of inhalation therapy, inhalers currently available, and especially major advances in inhalation therapy in pediatrics. SOURCES: Articles of MEDLINE database from 1983 were reviewed, in addition to book chapters, and the most important studies were selected according to the criteria established for this article. SUMMARY OF THE
FINDINGS: Conventional nebulizers have a number of inconveniences, and breath-enhanced and breath-actuated inhalers are more attractive options. Among dry powder inhalers, we highlight those using passive and active powder dispersion mechanisms, which provide higher rates of drug deposition in the lung. Among pressurized metered-dose inhalers, we highlight breath-actuated, breath-coordinated, and velocity-modifying inhalers. These inhalers should be used preferably together with spacers, since the use of spacers produces a twofold increase in pulmonary drug deposition.
CONCLUSIONS: For children younger than 8 years, pressurized metered-dose inhalers with spacers are the most appropriate devices, since they provide a practical approach associated with greater lung deposition. In children older than 8 years who can generate high inspiratory flow rates, dry powder devices are best suited.

Entities:  

Mesh:

Year:  2010        PMID: 20938588     DOI: 10.2223/JPED.2024

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  2 in total

Review 1.  Drug-targeting methodologies with applications: A review.

Authors:  Clement Kleinstreuer; Yu Feng; Emily Childress
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 2.  A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases.

Authors:  Siqin He; Jiajia Gui; Kun Xiong; Meiwan Chen; Huile Gao; Yao Fu
Journal:  J Nanobiotechnology       Date:  2022-03-03       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.